Improving surveillance for Barrett's oesophagus

British Medical Journal

Volumn 332, Issue 7553, 2006, Pages 1320-1323

  Bampton, Peter A ^a   Schloithe, Anne ^b   Bull, Jeff ^c   Fraser, Robert J ^c   Padbury, Rob T A ^a   Watson, David I ^b  

^a FLINDERS MEDICAL CENTRE   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

^c REPATRIATION GENERAL HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BARRETT ESOPHAGUS; DIGESTIVE TRACT ENDOSCOPY; DISEASE SURVEILLANCE; ENDOSCOPIC BIOPSY; FOLLOW UP; GENERAL HOSPITAL; HEALTH CARE COST; HEALTH PROGRAM; HUMAN; MEDICAL AUDIT; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SCREENING; TOTAL QUALITY MANAGEMENT; ADULT; ARTICLE; AUSTRALIA; CLINICAL TRIAL; MASS SCREENING; METHODOLOGY; MULTICENTER STUDY; RETROSPECTIVE STUDY;

ADULT; BARRETT ESOPHAGUS; GUIDELINE ADHERENCE; HUMANS; MASS SCREENING; MEDICAL AUDIT; PRACTICE GUIDELINES; RETROSPECTIVE STUDIES; SOUTH AUSTRALIA;

EID: 33744999836     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.332.7553.1320     Document Type: Review

References (13)

1. Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS. Is there publication bias in the reporting of cancer risk in Barretts oesophagus? Gastroenterology 2000;119:333-8.
2. Jankowski J, Provenzale D, Moayyedi P. Oesophageal adenocarcinoma arising from Barrett's metaplasia has regional variations in the West. Gastroenterology 2002;122:558-90.
3. Van Sandick JW, van Lanschot JJB, Kuiken BW, Tytgat GNJ, Offerhaus CJA, Obertop H. Impact of endoscopie biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut 1998;43:216-22.
4. Peters JH, Clark GWB, Ireland AP, Chandrasoma P, Smyrk TC, De Meester TR. Outcome of adenocarcinoma arising in Barrett's oesophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg 1994;108:813-21.
5. Fountoulakis A, Zafirellis KD, Dolan K, Dexter SPL, Martin IG, Sue-Ling HM. Effect of surveillance of Barrett's oesophagus on the clinical outcome of oesophageal cancer. Br J Surg 2004;91:997-1003.
6. British Society of Gastroenterology. Guidelines for the diagnosis and management of Barrett's columnar lined oesophagus. www.bsg.org.uk/bsgdisp1. php?id = 3f4a76385e42599499e9&h = 1&sh = 1&i = 1&b = 1&m = 00023 (accessed 2 May 2006).
7. Sampliner RE. Practice parameters committee of the American College of Gastroenterology. Practice guidelines on the diagnosis, surveillance and therapy of Barrett's oesophagus. Am J Gastroenterol 1998;93:1028-32.
8. The Society for Surgery of the Alimentary Tract (SSAT), American Gastroenterological Association (AGA), American Society for Gastrointestinal Endoscopy (ASGE) Consensus Panel. Management of Barrett's esophagus. J Gastrointest Surg 2000;4:115-6.
9. Mandal A, Playford RJ, Wicks C. Current practice in surveillance strategy for patients with Barrett's oesophagus in the UK. Aliment Pharmacol Ther 2003;17:1319-24.
10. Bampton PA, Sandford JJ, Young GP. Application of evidence based medicine improves colonoscopy resource utilisation in patients with a moderate risk of colorectal cancer. Med J Aust 2002;176:155-7.
11. Basu KK, Pick B, de Caestecker JS. Audit of a Barrett's epithelium surveillance database. Eur J Gastroenterol Hepatol 2004;16:17l-5.
12. Ramnath G, Bampton PA. Surveillance for Barrett's oesophagus-if you are going to do it, do it properly. Med J Aust 2004;180:139-40.
13. Miros M, Kerlin P, Walker N. Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus. Gut 1991;32:1441-6.